[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.141.60. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
July 21, 1962

Diuretic Therapy for Malignant Effusion

Author Affiliations

New Orleans

JAMA. 1962;181(3):258-260. doi:10.1001/jama.1962.03050290080017a
Abstract

RETENTION of fluid is often a most troublesome symptom of patients with cancer. Relieving the patient of abnormal collections of fluid makes him more comfortable and frequently enables him to resume his normal daily routine. We should like to review briefly the available therapy of this problem, emphasizing the beneficial results of oral administration of diuretic agents, particularly the thiazide diuretics and an aldosterone antagonist (spironolactone).

Successful antineoplastic chemotherapy is an effective answer to malignant effusion. If the malignant process cannot be controlled, local antineoplastic therapy may still be of benefit. Injection of oncolytic chemotherapeutic agents into the pleural or peritoneal space, after withdrawal of as much of the fluid as possible, can be an efficient longterm method of controlling effusion due to malignant tumors. Nitrogen mustard, 0.2 to 0.6 mg. per kilogram of body weight, is widely used for this purpose. Radioactive isotopes have also successfully controlled certain types

First Page Preview View Large
First page PDF preview
First page PDF preview
×